Indivior PLC Ordinary Shares (INDV)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $4.28B
Last updated: Nov 04, 2026 at 4:00 PM ET
Indivior PLC Ordinary Shares (INDV) Financials: Revenue, Profit and Cash Flow
Indivior PLC Ordinary Shares reported revenue of $1.24B for the fiscal year ended Dec 31, 2025, up 4.3% from the year before. That year, net income was $210.00M with a net margin of 16.9%, operating cash flow was -$27.00M and free cash flow was -$93.00M. The quarter ended Sep 30, 2026 had revenue of $356.00M and net income of $137.00M.
Revenue and Margins
The operating margin was 21.1% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $968.89M, a compound annual rate of 2.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.24B | +4.3% | 80.2% | 21.1% | 16.9% |
| Dec 2024 | $1.19B | +8.7% | 80.6% | 3.2% | 0.6% |
| Dec 2023 | $1.09B | +21.3% | 84.1% | -13.9% | -11.5% |
| Dec 2022 | $901.00M | +13.9% | 83.1% | -9.0% | -4.9% |
| Dec 2021 | $791.00M | +22.3% | 83.9% | 26.9% | 25.9% |
| Dec 2020 | $647.00M | -17.6% | 85.0% | -24.1% | -22.9% |
| Dec 2019 | $785.00M | -18.2% | 82.2% | 22.7% | 17.1% |
| Dec 2018 | $959.92M | -16.4% | 86.0% | 33.0% | 27.4% |
| Dec 2017 | $1.15B | +18.5% | 89.3% | 36.9% | 5.3% |
| Dec 2016 | $968.89M | N/A | 88.6% | 34.9% | 3.3% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 2900.0% from the year before. In the quarter ended Sep 2026, net income rose 226.2% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.24B | $1.19B | $1.09B | $901.00M | $791.00M | $647.00M | $785.00M | $959.92M | $1.15B | $968.89M |
| Cost of revenue | $246.00M | $231.00M | $174.00M | $151.00M | $127.00M | $97.00M | $140.00M | $134.68M | $122.90M | $110.81M |
| Gross profit | $994.00M | $957.00M | $919.00M | $749.00M | $664.00M | $550.00M | $645.00M | $825.25M | $1.03B | $858.08M |
| Research and development | $97.00M | $108.00M | $278.00M | $74.00M | $52.00M | $40.00M | $53.00M | $63.99M | $93.49M | $108.98M |
| Operating income | $262.00M | $38.00M | -$152.00M | -$81.00M | $213.00M | -$156.00M | $178.00M | $317.11M | $423.32M | $337.92M |
| Net income | $210.00M | $7.00M | -$126.00M | -$44.00M | $205.00M | -$148.00M | $134.00M | $262.67M | $60.92M | $32.05M |
| EBITDA | $282.00M | $66.00M | -$137.00M | -$65.00M | $260.00M | -$123.00M | $230.00M | N/A | $436.97M | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $356.00M | $343.00M | $317.00M | $357.00M | $314.00M | $302.00M | $266.00M | $298.00M | $307.00M | $299.00M | $284.00M | $293.00M |
| Gross profit | $305.00M | $294.00M | $277.00M | $293.00M | $230.00M | $250.00M | $221.00M | $250.00M | $241.00M | $220.00M | $246.00M | $242.00M |
| Operating income | $180.00M | $160.00M | $137.00M | $81.00M | $43.00M | $72.00M | $66.00M | $46.00M | $35.00M | -$118.00M | $75.00M | $61.00M |
| Net income | $137.00M | $122.00M | $89.00M | $103.00M | $42.00M | $18.00M | $47.00M | $21.00M | $22.00M | -$97.00M | $61.00M | $54.00M |
Balance Sheet
As of Dec 2025, total debt of $319.00M exceeded cash and equivalents by $124.00M. Shareholder equity was negative, at -$98.00M, as total liabilities of $1.30B exceeded total assets of $1.20B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.20B | $1.32B | $1.76B | $1.77B | $1.83B | $1.53B | $1.65B | $1.55B | $1.44B | $1.21B |
| Current assets | $652.00M | $827.00M | $1.27B | $1.26B | $1.44B | $1.19B | $1.36B | $1.33B | $1.22B | $990.00M |
| Cash and equivalents | $195.00M | $319.00M | $316.00M | $774.00M | $1.10B | $858.00M | $1.06B | $924.00M | $863.00M | $692.00M |
| Total liabilities | $1.30B | $1.65B | $1.95B | $1.72B | $1.63B | $1.45B | $1.44B | $1.48B | $1.65B | $1.50B |
| Short-term debt | $29.00M | $18.00M | $3.00M | $3.00M | $3.00M | $12.00M | $9.00M | $4.00M | $5.00M | $101.00M |
| Long-term debt | $290.00M | $315.00M | $237.00M | $237.00M | $239.00M | $230.00M | $233.00M | N/A | N/A | N/A |
| Shareholder equity | -$98.00M | -$337.00M | -$191.00M | $51.00M | $203.00M | $82.00M | $209.00M | $66.00M | -$203.00M | -$295.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.33B | $1.23B | $1.20B | $1.20B | $1.42B | $1.45B | $1.38B | $1.32B | $1.46B | $1.54B | $1.45B | $1.76B |
| Total liabilities | $1.39B | $1.44B | $1.34B | $1.30B | $1.62B | $1.71B | $1.66B | $1.67B | $1.63B | $1.66B | $1.44B | $1.96B |
| Cash and equivalents | $305.00M | $222.00M | $175.00M | $195.00M | $445.00M | $510.00M | $372.00M | $319.00M | $288.00M | $302.05M | $247.81M | $316.00M |
| Shareholder equity | -$60.00M | -$208.00M | -$144.00M | -$98.00M | -$207.00M | -$257.00M | -$285.00M | -$348.00M | -$167.00M | -$121.02M | $9.99M | -$191.00M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$27.00M | $36.00M | -$300.00M | -$4.00M | $353.00M | -$193.00M | $151.00M | $289.41M | $309.87M | $372.72M |
| Capital expenditures | $66.00M | $29.00M | $8.00M | $5.00M | $34.00M | $4.00M | $7.00M | $39.16M | $45.17M | $32.05M |
| Free cash flow | -$93.00M | $7.00M | -$308.00M | -$9.00M | $319.00M | -$197.00M | $144.00M | $250.25M | $264.70M | $340.67M |
| Dividends paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $63.19M |
| Share repurchases | $11.00M | $173.00M | $33.00M | $90.00M | $101.00M | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | -$66.00M | $69.00M | -$95.00M | -$222.00M | -$14.00M | -$4.00M | -$2.00M | -$3.82M | -$45.17M | -$32.05M |
| Financing cash flow | -$30.00M | -$102.00M | -$64.00M | -$101.00M | -$94.00M | -$10.00M | -$13.00M | -$226.37M | -$88.23M | -$134.62M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $97.00M | $229.00M | -$9.00M | -$221.00M | -$39.00M | $158.00M | $75.00M | -$17.00M | $2.00M | $88.00M | -$37.00M | -$279.72M |
| Capital expenditures | $14.00M | $7.00M | $20.00M | $24.00M | $20.00M | $17.00M | $5.00M | $16.00M | $7.00M | $4.00M | $2.00M | $3.91M |
| Free cash flow | $83.00M | $222.00M | -$29.00M | -$245.00M | -$59.00M | $141.00M | $70.00M | -$33.00M | -$5.00M | $84.00M | -$39.00M | -$283.62M |
Frequently Asked Questions About INDV
What is Indivior PLC Ordinary Shares' annual revenue?
Indivior PLC Ordinary Shares reported revenue of $1.24B for the fiscal year ended Dec 31, 2025.
How fast is Indivior PLC Ordinary Shares' revenue growing?
Revenue was up 4.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 11.2%.
Is Indivior PLC Ordinary Shares profitable?
Yes. Indivior PLC Ordinary Shares reported net income of $210.00M for the fiscal year ended Dec 31, 2025, with a net margin of 16.9%.
How much free cash flow does INDV generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$27.00M minus capital expenditures of $66.00M produced free cash flow of -$93.00M.
How much debt does Indivior PLC Ordinary Shares have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $290.00M, short-term debt of $29.00M and cash and equivalents of $195.00M.
INDV pages: Overview, Financials, Government Contracts